STOCK TITAN

Delixy Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

(Moderate)
(Negative)
Tags

Delixy Holdings (Nasdaq: DLXY) received a Nasdaq notification on April 23, 2026 for noncompliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

Based on closing bids from March 11, 2026 to April 22, 2026 (30 consecutive business days), the company has until October 20, 2026 to regain compliance by closing at or above $1.00 for 10 consecutive business days. The listing is unaffected for now; the company may consider options such as a reverse stock split.

Loading...
Loading translation...

Positive

  • Nasdaq granted a 180-day cure period through October 20, 2026
  • Current Nasdaq listing remains intact while the company seeks compliance
  • Company operations are stated as unaffected by the notification

Negative

  • Class A shares failed the $1.00 minimum bid requirement over 30 business days
  • Risk of delisting if compliance is not regained by October 20, 2026
  • Potential shareholder dilution or change in capital structure if a reverse split is implemented

News Market Reaction – DLXY

-8.56%
7 alerts
-8.56% Session close to close
+6.1% Peak Tracked
-5.0% Trough Tracked
$12.59M Market Cap
0.1x Rel. Volume

In the Apr 30 session, DLXY declined 8.56%, reflecting a notable negative market reaction. Argus tracked a peak move of +6.1% during that session. Argus tracked a trough of -5.0% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -8.6% in the session following this news. A negative reaction to the Nasdaq bid-pric...
Analysis

The stock moved -8.6% in the session following this news. A negative reaction to the Nasdaq bid-price deficiency notice would be consistent with elevated listing-risk for a stock already trading at US$0.7581, well below the US$1.00 minimum. This contrasts with earlier news that coincided with gains of 19.84% and 67.86%. The need to achieve at least 10 consecutive days above US$1.00 before October 20, 2026 could keep compliance concerns in focus.

Key Figures

Minimum bid price: US$1.00 per share Deficiency period: 30 consecutive business days Compliance window: 180 calendar days +3 more
6 metrics
Minimum bid price US$1.00 per share Nasdaq Listing Rule 5550(a)(2) requirement
Deficiency period 30 consecutive business days Period of sub-US$1.00 bid triggering deficiency
Compliance window 180 calendar days Time granted to regain compliance, until October 20, 2026
Compliance threshold 10 consecutive business days Required period with bid at or above US$1.00
Current price US$0.7581 Below Nasdaq US$1.00 minimum bid requirement
52-week range US$0.45 – US$7.16 Shares <b>89.41%</b> below 52-week high pre-notice

Historical Context

2 past events · Latest: Apr 21 (Positive)
Pattern 2 events
Date Event Sentiment 24h Move Catalyst
Apr 21 Chairman letter Positive +19.8% Chairman outlined 2025 performance, doubled operating profit and 2026 strategy.
Dec 30 Earnings update Positive +67.9% Reported H1 2025 financials with higher net income and lower expenses post-IPO.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news has coincided with strong positive price reactions, suggesting headlines have been meaningful catalysts.

Recent Company History

Over the last year, Delixy’s key disclosures focused on strategy and early financials. A 2026 chairman’s letter highlighting doubled operating profit in H1 2025 and expansion plans saw a 19.84% gain. Unaudited H1 2025 results, with $102.0M revenue and improved net income to $0.6M, coincided with a 67.86% rise. Against that backdrop, a Nasdaq bid-price deficiency notice marks a shift from growth and governance themes toward listing compliance risk.

Key Terms

minimum bid price requirement, nasdaq capital market, reverse stock split
3 terms
minimum bid price requirement regulatory
"not in compliance with the minimum bid price requirement set forth in the Nasdaq"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
nasdaq capital market regulatory
"The Notification Letter does not impact the Company’s listing on the Nasdaq Capital Market"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
reverse stock split financial
"including, but not limited to, implementing a reverse stock split of its outstanding"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SINGAPORE, April 29, 2026 (GLOBE NEWSWIRE) -- Delixy Holdings Limited (Nasdaq: DLXY) (the “Company” or “Delixy”), a Singapore-based company engaged in the trading of oil related products, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on April 23, 2026, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq.

Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the Company’s Class A ordinary shares for the 30 consecutive business days from March 11, 2026 to April 22, 2026, the Company no longer meets the minimum bid price requirement.

The Notification Letter does not impact the Company’s listing on the Nasdaq Capital Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until October 20, 2026, to regain compliance with Nasdaq Listing Rule 5550(a)(2). To regain compliance, the Company’s Class A ordinary shares must have a closing bid price of at least US$1.00 for a minimum of 10 consecutive business days. In the event the Company does not regain compliance by October 20, 2026, the Company may be eligible for additional time to regain compliance or may face delisting.

The Company’s business operations are not affected by the receipt of the Notification Letter. The Company intends to monitor the closing bid price of its Class A ordinary shares and may, if appropriate, consider implementing available options, including, but not limited to, implementing a reverse stock split of its outstanding Class A ordinary shares, to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules.

About Delixy Holdings Limited

Delixy Holdings Limited is a Singapore-based company principally engaged in the trading of oil-related products, including (i) crude oil and (ii) oil-based products such as fuel oil, motor gasoline, additives, gas oil, base oil, asphalt, naphtha (heavy gasoline) and petrochemicals. Operating across multiple countries in Southeast Asia, East Asia, and Middle East, Delixy has established a strong presence in the region's oil trading markets. While Delixy maintains a diversified portfolio of oil products, crude oil trading represents a core aspect of its business. The Company leverages its strong existing relationships with customers and suppliers as well as deep industry expertise to provide value-added services, including tailored recommendations on optimal trading strategies and shipping and logistical support where required. In addition, the Company's financing capabilities allow it to extend credit terms to customers while satisfying suppliers' immediate payment terms. For more information, please visit the Company's website: https://ir.delixy.com.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can find many (but not all) of these statements by the use of words such as “believe”, “plan”, “expect”, “intend”, “should”, “seek”, “estimate”, “will”, “aim” and “anticipate” or other similar expressions in this prospectus. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Registration Statement and other filings with the U.S. Securities and Exchange Commission (the “SEC”).

For media inquiries, please contact:

Delixy Holdings Limited
Investor Relations Department
Email: ir@delixy.com

Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com


FAQ

What did Delixy (DLXY) announce about Nasdaq minimum bid price noncompliance?

Delixy received a Nasdaq notification for failing the $1.00 minimum bid requirement. According to the company, closing bids from March 11, 2026 to April 22, 2026 produced a 30-business-day deficiency, triggering a 180-day cure period to regain compliance.

How long does Delixy (DLXY) have to regain compliance with Nasdaq rules?

Delixy has 180 calendar days to regain compliance, until October 20, 2026. According to the company, compliance requires a closing bid at or above $1.00 for at least 10 consecutive business days within that cure period.

What happens if Delixy (DLXY) does not regain the $1.00 minimum bid by October 20, 2026?

If compliance is not regained by October 20, 2026, Delixy may be eligible for additional time or may face delisting. According to the company, Nasdaq could either grant extra time or initiate delisting procedures.

Will the Nasdaq notification affect Delixy’s business operations or listing right away?

The Nasdaq notice does not affect Delixy’s listing immediately and the company says operations are unaffected. According to the company, the notice only triggers the compliance process and a potential cure period.

What options might Delixy (DLXY) consider to regain Nasdaq compliance?

Delixy may consider actions such as a reverse stock split to raise the per-share price. According to the company, management will monitor the closing bid and may implement available measures if appropriate to regain compliance.